Recursion Pharmaceuticals Inc (RXRX) showcases strong financial management and strategic partnerships while navigating challenges in drug discovery.

Recursion Pharmaceuticals Inc .股价创下新的52周低点，收盘价为3.53美元，距离其52周绝对最低点3.54美元仅差几分钱。这一里程碑标志着该公司的重大下滑， InvestingPro 数据显示，过去一年该股价下跌了55.52%。根据InvestingPro的公允价值评估，该股票在当前水平略显低估。这家以通过机器学习和自动化进行创新药物发现而闻名的生物制药公司在市场上 ...

The consensus estimate for Q4 2025 revenue is $24.59 million, and the earnings are expected to come in at -$0.27 per share. The full year 2025's revenue is expected to be $61.58 million and the ...

Cathie Wood旗下ARK ETF公布了2026年2月18日周三的每日交易记录,显示其在生物科技和科技板块的重大调仓活动。当日最大的一笔交易是买入1,251,270股 Recursion Pharmaceuticals Inc ...

Recursion Pharmaceuticals Inc RXRX shares are under pressure Wednesday after new regulatory filings showed that Nvidia Corp ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most promising penny stocks under $5 to buy. On February 25, ...

Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, delighted to be joining you on our L(earnings) today. And I'm joined by our Chief R&D and Commercial Officer, Najat Khan and ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Recursion Pharmaceuticals' stock experienced a 10.06% surge on Monday, indicating strong investor confidence in the company's innovations. The completion of BioHive-2 marks a pivotal moment for ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is ...

We recently compiled a list of the Last Week’s Top 10 Stocks Post Double-Digit Gains. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against ...